Cargando…

515. Estimating the Effect of Proton Pump Inhibitor Stewardship in Reducing Clostridium difficile Transmission

BACKGROUND: Antibiotic stewardship programs (ASPs) have been successful in reducing the incidence of Clostridium difficile (CDI) by reducing patient exposure to antibiotics, especially fluoroquinolones. Proton pump inhibitors (PPIs), while less pronounced as a risk factor for CDI, are widespread in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lofgren, Eric, Moehring, Rebekah W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254251/ http://dx.doi.org/10.1093/ofid/ofy210.524

Ejemplares similares

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
por: Tawam, Dania, et al.
Publicado: (2021)

2341. Effectiveness of Interventions Targeting Stewardship of Clostridium difficile Testing
por: Sterling, Stephanie, et al.
Publicado: (2019)

Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021)

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T, et al.
Publicado: (2014)

Clostridium difficile Laboratory Identification Event Reporting – A Need for Diagnostic Stewardship
por: Rock, Clare, et al.
Publicado: (2017)

Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T., et al.
Publicado: (2016)

Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
por: Bradley, Evan Stuart, et al.
Publicado: (2019)

The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
por: Wenzler, Eric, et al.
Publicado: (2015)

504. Change in Clostridium difficile Strain-Type Distribution After Implementation of Diagnostic Stewardship
por: McMillen, Tracy, et al.
Publicado: (2018)

521. Clostridium difficile Timeout: A Nurse-Driven Protocol to Optimize Testing Stewardship
por: Hou, Cindy, et al.
Publicado: (2018)

239. Implementation of a Vertical Antimicrobial Stewardship Intervention for Patients Colonized with Clostridium difficile
por: Revolinski, Sara, et al.
Publicado: (2018)

2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
por: Panagos, Katherine, et al.
Publicado: (2019)

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients
por: Pohl, John F., et al.
Publicado: (2011)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Evaluating the Effectiveness of an Antimicrobial Stewardship Intervention on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection
por: Didiodato, Giulio, et al.
Publicado: (2015)

1986. Impact of Two-Step Testing on the Diagnosis and Management of Clostridium difficile in a Multi-Hospital Healthcare System
por: Davis, Angelina, et al.
Publicado: (2019)

2159. Methodological Threats to the Standardized Infection and Standardized Antimicrobial Administration Ratios
por: Lofgren, Eric, et al.
Publicado: (2018)

Enhanced Cleaning and Education to Prevent Transmission of Clostridium difficile in Pediatrics
por: Aslam, Anoshé, et al.
Publicado: (2017)

2428. Whole-genome Sequencing to Determine Clostridium difficile Transmission
por: Madigan, Victoria M, et al.
Publicado: (2019)

527. New Robust Antimicrobial Stewardship Program (ASP) Results in Reduction of Clostridium difficile 30-Day Readmission
por: Anthone, Jennifer, et al.
Publicado: (2018)

Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy
por: Dos Santos-Schaller, Ophélie, et al.
Publicado: (2016)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?
por: Patil, Rashmee, et al.
Publicado: (2013)

1244. Antimicrobial Stewardship Knowledge, Attitudes, and Practices (KAP) Among Nurses
por: Hayes, Jillian E, et al.
Publicado: (2023)

Clostridium: Transmission difficile?
por: Harbarth, Stephan, et al.
Publicado: (2012)

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016)

802. Proton Pump Inhibitors Increase Clostridioides difficile Disease Severity Controlling for Infecting Strains
por: Fallatah, Saad, et al.
Publicado: (2020)

A Successful Strategy to Reduce Hospital-Onset Clostridium difficile
por: Bruno-Murtha, Lou Ann, et al.
Publicado: (2017)

531. Reducing Inappropriate Hospital-Acquired Clostridium difficile Diagnoses
por: Duncan, Robert, et al.
Publicado: (2018)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

1646 Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
por: Galdys, Alison, et al.
Publicado: (2014)

Reduction of Clostridium difficile Infection in a Community Teaching Hospital Associated with Antimicrobial Stewardship Team Interventions on Fluoroquinolone Utilization
por: Politis, Paula, et al.
Publicado: (2017)

1413. Effect of Automated Identification of Antimicrobial Stewardship Opportunities for Urinary Tract Infections
por: Deri, Connor, et al.
Publicado: (2021)

Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-Analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2012)

Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
por: Ro, Youngouk, et al.
Publicado: (2016)

1186. Beta is Better: Impact of a Multifaceted Stewardship Initiative on the Sequential Timing of Beta-Lactam Administration
por: Deri, Connor R, et al.
Publicado: (2023)

National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China
por: Xiao, Meng, et al.
Publicado: (2017)

A Multi-Faceted Antimicrobial Stewardship Program (ASP) Intervention Using Clinical Pharmacists Reduces Antibiotic Use and Hospital-Acquired Clostridium difficile Infection (HA-CDI)
por: Boyd, Anthony M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a8lu9ici2jr3d8b2mcfcl30ac9